TG THERAPEUTICS, INC. Operating Expenses
TG THERAPEUTICS, INC. (TGTX) reported Operating Expenses of $60.75 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-08-04
- TG THERAPEUTICS, INC. operating expenses for the quarter ending 2023-06-30 was $60.75M, a 53.66% increase year-over-year.
- TG THERAPEUTICS, INC. operating expenses for the quarter ending 2023-03-31 was $44.80M, a 34.97% decline year-over-year.
- TG THERAPEUTICS, INC. operating expenses for the quarter ending 2022-12-31 was $52.14M, a 45.27% decline year-over-year.
- TG THERAPEUTICS, INC. operating expenses for the quarter ending 2022-09-30 was $35.06M, a 59.78% decline year-over-year.
- TG THERAPEUTICS, INC. operating expenses for fiscal 2022 was $195.62M, a 44.34% decline from fiscal 2021.
- TG THERAPEUTICS, INC. operating expenses for fiscal 2021 was $351.46M, a 28.39% increase from fiscal 2020.
- TG THERAPEUTICS, INC. operating expenses for fiscal 2020 was $273.75M, a 61.78% increase from fiscal 2019.
- TG THERAPEUTICS, INC. operating expenses for fiscal 2019 was $169.21M, a 3.06% decline from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 13 month | Operating Expenses 15 month | Operating Expenses 16 month | Operating Expenses 18 month | Operating Expenses 19 month | Operating Expenses 22 month | Operating Expenses 25 month | Operating Expenses 28 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $60.75M 10-Q · filed 2023-08-04 | $105.54M 10-Q · filed 2023-08-04 | $157.69M derived: sum of 3 quarters · filed 2023-08-04 | $192.74M derived: sum of 4 quarters · filed 2023-08-04 | ||||||||||||
| 2023-03-31 | $44.80M 10-Q · filed 2023-05-08 | $96.94M derived: sum of 2 quarters · filed 2023-05-08 | $131.99M derived: sum of 3 quarters · filed 2023-05-08 | $171.53M derived: sum of 4 quarters · filed 2023-08-04 | ||||||||||||
| 2022-12-31 | $52.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $87.20M derived: sum of 2 quarters · filed 2023-03-01 | $126.73M derived: sum of 3 quarters · filed 2023-08-04 | $195.62M 10-K · filed 2023-03-01 | ||||||||||||
| 2022-09-30 | $35.06M 10-Q · filed 2022-11-09 | $74.59M derived: sum of 2 quarters · filed 2023-08-04 | $143.48M 10-Q · filed 2022-11-09 | $238.75M derived: sum of 4 quarters · filed 2023-08-04 | ||||||||||||
| 2022-06-30 | $39.53M 10-Q · filed 2023-08-04 | $108.42M 10-Q · filed 2023-08-04 | $203.69M derived: sum of 3 quarters · filed 2023-08-04 | $290.85M derived: sum of 4 quarters · filed 2023-08-04 | ||||||||||||
| 2022-03-31 | $68.89M 10-Q · filed 2023-05-08 | $164.16M derived: sum of 2 quarters · filed 2023-05-08 | $251.31M derived: sum of 3 quarters · filed 2023-05-08 | $330.35M derived: sum of 4 quarters · filed 2023-05-08 | ||||||||||||
| 2021-12-31 | $95.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $182.43M derived: sum of 2 quarters · filed 2023-03-01 | $261.46M derived: sum of 3 quarters · filed 2023-03-01 | $351.46M 10-K · filed 2023-03-01 | ||||||||||||
| 2021-09-30 | $87.16M 10-Q · filed 2022-11-09 | $166.19M derived: sum of 2 quarters · filed 2022-11-09 | $256.19M 10-Q · filed 2022-11-09 | $343.01M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||
| 2021-06-30 | $79.04M 10-Q · filed 2022-08-09 | $169.03M 10-Q · filed 2022-08-09 | $255.85M derived: sum of 3 quarters · filed 2023-03-01 | $341.61M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||
| 2021-03-31 | $90.00M 10-Q · filed 2022-05-10 | $176.81M derived: sum of 2 quarters · filed 2023-03-01 | $262.57M derived: sum of 3 quarters · filed 2023-03-01 | $313.46M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||
| 2020-12-31 | $86.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $172.58M derived: sum of 2 quarters · filed 2023-03-01 | $223.46M derived: sum of 3 quarters · filed 2023-03-01 | $273.75M 10-K · filed 2023-03-01 | ||||||||||||
| 2020-09-30 | $85.76M 10-Q · filed 2021-11-08 | $136.64M derived: sum of 2 quarters · filed 2021-11-08 | $186.93M 10-Q · filed 2021-11-08 | $224.92M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||
| 2020-06-30 | $50.88M 10-Q · filed 2021-08-06 | $101.17M 10-Q · filed 2021-08-06 | $139.16M derived: sum of 3 quarters · filed 2021-08-06 | $200.06M derived: sum of 4 quarters · filed 2021-08-06 | ||||||||||||
| 2020-03-31 | $50.28M 10-Q · filed 2021-05-10 | $88.28M derived: sum of 2 quarters · filed 2021-05-10 | $149.18M derived: sum of 3 quarters · filed 2021-05-10 | $184.76M derived: sum of 4 quarters · filed 2021-05-10 | ||||||||||||
| 2019-12-31 | $38.00M 10-K · filed 2020-03-02 | $98.90M derived: sum of 2 quarters · filed 2020-11-09 | $134.48M derived: sum of 3 quarters · filed 2020-11-09 | $169.21M 10-K · filed 2022-03-01 | ||||||||||||
| 2019-09-30 | $60.90M 10-Q · filed 2020-11-09 | $96.48M derived: sum of 2 quarters · filed 2020-11-09 | $131.21M 10-Q · filed 2020-11-09 | $185.40M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | $35.58M 10-Q · filed 2020-08-10 | $70.31M 10-Q · filed 2020-08-10 | $124.50M derived: sum of 3 quarters · filed 2020-08-10 | $158.86M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $34.73M 10-Q · filed 2020-05-11 | $88.92M derived: sum of 2 quarters · filed 2020-05-11 | $123.28M derived: sum of 3 quarters · filed 2020-05-11 | $167.66M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | $54.19M 10-K · filed 2020-03-02 | $88.55M derived: sum of 2 quarters · filed 2020-03-02 | $132.94M derived: sum of 3 quarters · filed 2020-03-02 | $174.55M 10-K · filed 2021-03-01 | ||||||||||||
| 2018-09-30 | $34.37M 10-K · filed 2020-03-02 | $78.75M derived: sum of 2 quarters · filed 2020-03-02 | $120.36M 10-Q · filed 2019-11-12 | $151.44M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2018-06-30 | $44.38M 10-K · filed 2020-03-02 | $86.00M 10-Q · filed 2019-08-09 | $117.07M derived: sum of 3 quarters · filed 2020-03-02 | $148.69M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||
| 2018-03-31 | $41.62M 10-K · filed 2020-03-02 | $40.62M 10-Q · filed 2018-05-10 | $72.69M derived: sum of 2 quarters · filed 2020-03-02 | $104.31M derived: sum of 3 quarters · filed 2020-03-02 | $132.77M derived: sum of 4 quarters · filed 2020-03-02 | |||||||||||
| 2017-12-31 | $31.07M 10-K · filed 2019-03-01 | $31.07M 10-K · filed 2018-03-15 | $62.70M derived: sum of 2 quarters · filed 2019-03-01 | $91.16M derived: sum of 3 quarters · filed 2019-03-01 | $118.86M 10-K · filed 2020-03-02 | $118.86M 10-K · filed 2018-03-15 | ||||||||||
| 2017-09-30 | $31.62M 10-K · filed 2019-03-01 | $31.62M 10-Q · filed 2017-11-09 | $60.09M derived: sum of 2 quarters · filed 2019-03-01 | $87.79M 10-Q · filed 2018-11-09 | $87.79M 10-Q · filed 2017-11-09 | $111.86M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||
| 2017-06-30 | $28.46M 10-K · filed 2019-03-01 | $28.46M 10-Q · filed 2017-08-09 | $56.17M 10-Q · filed 2018-08-09 | $56.17M 10-Q · filed 2017-08-09 | $80.23M derived: sum of 3 quarters · filed 2019-03-01 | $105.20M derived: sum of 4 quarters · filed 2019-03-01 | ||||||||||
| 2017-03-31 | $27.70M 10-K · filed 2019-03-01 | $27.70M 10-Q · filed 2017-05-10 | $51.77M derived: sum of 2 quarters · filed 2019-03-01 | $76.73M derived: sum of 3 quarters · filed 2019-03-01 | $92.80M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||
| 2016-12-31 | $24.07M 10-K · filed 2018-03-15 | $49.03M derived: sum of 2 quarters · filed 2018-03-15 | $65.09M derived: sum of 3 quarters · filed 2018-03-15 | $79.12M 10-K · filed 2019-03-01 | $79.12M 10-K · filed 2017-03-16 | |||||||||||
| 2016-09-30 | $24.96M 10-K · filed 2018-03-15 | $41.03M derived: sum of 2 quarters · filed 2018-03-15 | $55.06M 10-Q · filed 2017-11-09 | $72.73M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||
| 2016-06-30 | $16.06M 10-K · filed 2018-03-15 | $30.09M 10-Q · filed 2017-08-09 | $47.77M derived: sum of 3 quarters · filed 2018-03-15 | $61.63M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||
| 2016-03-31 | $14.03M 10-K · filed 2018-03-15 | $31.71M derived: sum of 2 quarters · filed 2018-03-15 | $45.57M derived: sum of 3 quarters · filed 2018-03-15 | $62.72M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||
| 2015-12-31 | $17.68M 10-K · filed 2017-03-16 | $31.54M derived: sum of 2 quarters · filed 2017-03-16 | $48.69M derived: sum of 3 quarters · filed 2017-03-16 | $63.33M 10-K · filed 2018-03-15 | ||||||||||||
| 2015-09-30 | $13.86M 10-K · filed 2017-03-16 | $31.01M derived: sum of 2 quarters · filed 2017-03-16 | $45.65M 10-Q · filed 2016-11-09 | $64.41M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2015-06-30 | $17.15M 10-K · filed 2017-03-16 | $31.79M 10-Q · filed 2016-08-09 | $50.55M derived: sum of 3 quarters · filed 2017-03-16 | $68.03M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2015-03-31 | $14.64M 10-K · filed 2017-03-16 | $33.40M derived: sum of 2 quarters · filed 2017-03-16 | $50.88M derived: sum of 3 quarters · filed 2017-03-16 | $62.87M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2014-12-31 | $18.76M 10-K · filed 2016-03-15 | $36.24M derived: sum of 2 quarters · filed 2016-03-15 | $48.23M derived: sum of 3 quarters · filed 2016-03-15 | $55.87M 10-K · filed 2017-03-16 | ||||||||||||
| 2014-09-30 | $17.48M 10-K · filed 2016-03-15 | $29.47M derived: sum of 2 quarters · filed 2016-03-15 | $37.11M 10-Q · filed 2015-11-09 | $45.13M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-06-30 | $11.99M 10-K · filed 2016-03-15 | $19.64M 10-Q · filed 2015-08-10 | $27.65M derived: sum of 3 quarters · filed 2016-03-15 | $32.34M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-03-31 | $7.64M 10-K · filed 2016-03-15 | $15.66M derived: sum of 2 quarters · filed 2016-03-15 | $20.34M derived: sum of 3 quarters · filed 2016-03-15 | $27.01M derived: sum of 4 quarters · filed 2016-03-15 | $58.56M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $8.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $12.70M derived: sum of 2 quarters · filed 2016-03-15 | $19.37M derived: sum of 3 quarters · filed 2016-03-15 | $23.12M 10-K · filed 2016-03-15 | $50.91M 10-K · filed 2014-03-07 | |||||||||||
| 2013-09-30 | $4.69M 10-Q · filed 2014-11-14 | $11.35M derived: sum of 2 quarters · filed 2014-11-14 | $15.10M 10-Q · filed 2014-11-14 | $18.81M derived: sum of 4 quarters · filed 2014-11-14 | $42.90M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $6.67M 10-Q · filed 2014-07-24 | $10.42M 10-Q · filed 2014-07-24 | $14.13M derived: sum of 3 quarters · filed 2014-07-24 | $16.84M derived: sum of 4 quarters · filed 2014-07-24 | $38.22M 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $3.75M 10-Q · filed 2014-05-14 | $7.46M derived: sum of 2 quarters · filed 2014-05-14 | $10.18M derived: sum of 3 quarters · filed 2014-05-14 | $13.28M derived: sum of 4 quarters · filed 2014-05-14 | $31.55M 10-Q · filed 2013-05-14 | |||||||||||
| 2012-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $6.42M derived: sum of 2 quarters · filed 2014-03-07 | $9.53M derived: sum of 3 quarters · filed 2014-03-07 | $26.91M 10-K · filed 2014-03-07 | $27.80M 10-K · filed 2013-03-21 | |||||||||||
| 2012-09-30 | $2.71M 10-Q · filed 2013-11-14 | $5.82M derived: sum of 2 quarters · filed 2013-11-14 | $23.20M 10-Q · filed 2013-11-14 | $23.76M derived: sum of 4 quarters · filed 2013-11-14 | $24.09M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $3.10M 10-Q · filed 2013-08-09 | $20.49M 10-Q · filed 2013-08-09 | $21.05M derived: sum of 3 quarters · filed 2013-08-09 | $21.08M derived: sum of 4 quarters · filed 2013-08-09 | $21.37M 10-Q/A · filed 2012-09-07 | |||||||||||
| 2012-03-31 | $17.39M 10-Q · filed 2013-05-14 | $17.94M derived: sum of 2 quarters · filed 2013-05-14 | $17.97M derived: sum of 3 quarters · filed 2013-05-14 | $18.27M 10-Q · filed 2012-05-14 | ||||||||||||
| 2011-12-31 | $554.86K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $584.97K derived: sum of 2 quarters · filed 2013-03-21 | $881.97K derived: sum of 3 quarters · filed 2013-03-21 | $881.97K 10-K · filed 2013-03-21 | ||||||||||||
| 2011-09-30 | $30.11K 10-Q · filed 2012-11-14 | $327.12K derived: sum of 2 quarters · filed 2012-11-14 | $327.12K 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $297.00K 10-Q/A · filed 2012-09-07 | $297.00K 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |